Individualizing treatment choices in the systolic blood pressure intervention trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Individualizing treatment choices in the systolic blood pressure intervention trial

Published:2018-02 Issue:2 Volume:36 Page:428-435
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Ferreira João Pedro,Gregson John,Duarte Kévin,Gueyffier François,Rossignol Patrick,Zannad Faiez,Pocock Stuart

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference23 articles.

1. Better reporting of harms in randomized trials: an extension of the CONSORT statement;Ioannidis;Ann Intern Med,2004

2. The primary outcome is positive: is that good enough?;Pocock;N Engl J Med,2016

3. A randomized trial of intensive versus standard blood-pressure control;Wright;N Engl J Med,2015

4. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the systolic blood pressure intervention trial (SPRINT);Ambrosius;Clin Trials,2014

5. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group;Levey;Ann Intern Med,1999

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantifying the benefit-risk trade-off for individual patients in a clinical trial: principles and antithrombotic case study;Journal of Thrombosis and Haemostasis;2024-05

2. Planning Benefit-Risk Assessments Using Visualizations;Therapeutic Innovation & Regulatory Science;2023-09-08

3. Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroups;American Heart Journal;2022-05

4. Kidney tubule health, mineral metabolism and adverse events in persons with CKD in SPRINT;Nephrology Dialysis Transplantation;2021-09-02

5. Blood pressure reduction and anti‐hypertensive treatment choice: A post‐hoc analysis of the SPRINT trial;Clinical Cardiology;2021-04-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3